Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study
Authors:
- Mikhael GiabicaniMGMikhael Giabicani
- Christophe Le TerrierCTChristophe Le Terrier
- Antoine PoncetAPAntoine Poncet
- Bertrand GuidetBGBertrand Guidet
- Jean-Pierre QuenotJQJean-Pierre Quenot
- Marie-France MamzerMMMarie-France Mamzer
- Jérôme PuginJPJérôme Pugin
- Emmanuel WeissEWEmmanuel Weiss
- Simon BourcierSBSimon Bourcier
Open Access
- 11 March 2023
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 27 (1) , 1-14
Abstract
Background: Limitations of life-sustaining therapies (LST) practices are frequent and vary among intensive care units (ICUs). However, scarce data were available during the COVID-19 pandemic when ICUs were under intense pressure. We aimed to investigate the prevalence, cumulative incidence, timing, modalities, and factors associated with LST decisions in critically ill COVID-19 patients. Methods: We did an ancillary analysis of the European multicentre COVID-ICU study, which collected data from 163 ICUs in France, Belgium and Switzerland. ICU load, a parameter reflecting stress on ICU capacities, was calculated at the patient level using daily ICU bed occupancy data from official country epidemiological reports. Mixed effects logistic regression was used to assess the association of variables with LST limitation decisions. Results: Among 4671 severe COVID-19 patients admitted from February 25 to May 4, 2020, the prevalence of in-ICU LST limitations was 14.5%, with a nearly six-fold variability between centres. Overall 28-day cumulative incidence of LST limitations was 12.4%, which occurred at a median of 8 days (3–21). Median ICU load at the patient level was 126%. Age, clinical frailty scale score, and respiratory severity were associated with LST limitations, while ICU load was not. In-ICU death occurred in 74% and 95% of patients, respectively, after LST withholding and withdrawal, while median survival time was 3 days (1–11) after LST limitations. Conclusions: In this study, LST limitations frequently preceded death, with a major impact on time of death. In contrast to ICU load, older age, frailty, and the severity of respiratory failure during the first 24 h were the main factors associated with decisions of LST limitations.Keywords
All Related Versions
Funding Information
- University of Geneva
This publication has 31 references indexed in Scilit:
- Patient Mortality Is Associated With Staff Resources and Workload in the ICUCritical Care Medicine, 2015
- Variation in Decisions to Forgo Life-Sustaining Therapies in US ICUsChest, 2014
- Mortality among Patients Admitted to Strained Intensive Care UnitsAmerican Journal of Respiratory and Critical Care Medicine, 2013
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- End-of-life decisions: a cohort study of the withdrawal of all active treatment in intensive care units in the United KingdomIntensive Care Medicine, 2005
- End-of-Life Practices in European Intensive Care UnitsJAMA, 2003
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993